B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ephrin A2

174 PubMed studies analyzed ยท Evidence Score: 42.8

Research Domains

Ephrin A2 has been studied across 18 research domains including ๐Ÿ”ฌ Oncology, ๐Ÿ‘๏ธ Vision & Eye, ๐Ÿง  Learning, ๐Ÿ˜ด Sleep, ๐Ÿฆด Bone & Joint. The primary research focus is ๐Ÿ”ฌ Oncology with 16% of studies addressing this area.

Loading evidence profile...

This evidence profile for Ephrin A2 is generated deterministically from 174 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.